Our History
Track and record of
success in oncology
2009
Accelera was born
2010
AAALAC Accreditation
2011
Accelera is selected for inclusion within the European Union Network of Laboratories for the Validation of Alternative Methods (EU-NETVAL), established by the EU Commission
2012
Collaboration with Medicine for Malaria Venture, for antimalarial drugs in order to select those with the least toxic effect possible
2013
Collaboration with Karolinska development
2014
Collaboration with Cellectis to complete preclinical studies of Cellectis’ lead product cadidate UCART19
2015
Starting activity with CAR-T cells
– Efficacy models
– Pilot studies for cell engrafment, tolerability, surgical implantation
– GLP cell fate/biodistribution by FACS analysis
– GLP safety (toxicology)
– GLP tumorigenicity
– Pathology and necropsy
– Immunohistochemistry, qPCR/ddPCR
Headline news: Gene therapy saves a 1-year-old girl from leukemia
Collaboration with the Politecnico of Milan for the development of organ-on-chip technology on cardiomyocytes
Proud to be among DNI partners
DNDi and partners developed a breakthrough treatment for sleeping sickness






